Cite

HARVARD Citation

    Ward, C. et al. (2022). Suicidal and self‐injurious behavior following adalimumab reference‐to‐generic biosimilar switch. Psychiatry and clinical neurosciences. 76 (2), pp. 59-62. [Online]. 
  
Back to record